BRKR vs. STE: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at BRKR and STE, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
| Symbol | BRKR | STE |
|---|---|---|
| Company Name | Bruker Corporation | STERIS plc |
| Country | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry | Life Sciences Tools & Services | Health Care Equipment & Supplies |
| Market Capitalization | 5.24 billion USD | 24.33 billion USD |
| Exchange | NasdaqGS | NYSE |
| Listing Date | August 4, 2000 | June 1, 1992 |
| Security Type | Common Stock | Common Stock |
Historical Performance
This chart compares the performance of BRKR and STE by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
| Symbol | BRKR | STE |
|---|---|---|
| 5-Day Price Return | 10.85% | 4.58% |
| 13-Week Price Return | -14.21% | 5.99% |
| 26-Week Price Return | -38.34% | 9.59% |
| 52-Week Price Return | -42.83% | 5.61% |
| Month-to-Date Return | -10.12% | 9.09% |
| Year-to-Date Return | -41.08% | 20.19% |
| 10-Day Avg. Volume | 4.39M | 0.68M |
| 3-Month Avg. Volume | 2.92M | 0.65M |
| 3-Month Volatility | 58.88% | 27.38% |
| Beta | 1.21 | 1.02 |
Profitability
Return on Equity (TTM)
BRKR
4.42%
Life Sciences Tools & Services Industry
- Max
- 19.96%
- Q3
- 11.55%
- Median
- 6.22%
- Q1
- 3.86%
- Min
- -6.95%
BRKR’s Return on Equity of 4.42% is on par with the norm for the Life Sciences Tools & Services industry, indicating its profitability relative to shareholder equity is typical for the sector.
STE
9.47%
Health Care Equipment & Supplies Industry
- Max
- 34.53%
- Q3
- 19.38%
- Median
- 9.52%
- Q1
- 4.86%
- Min
- -7.58%
STE’s Return on Equity of 9.47% is on par with the norm for the Health Care Equipment & Supplies industry, indicating its profitability relative to shareholder equity is typical for the sector.
Net Profit Margin (TTM)
BRKR
2.31%
Life Sciences Tools & Services Industry
- Max
- 27.28%
- Q3
- 16.17%
- Median
- 7.24%
- Q1
- 3.00%
- Min
- -3.05%
Falling into the lower quartile for the Life Sciences Tools & Services industry, BRKR’s Net Profit Margin of 2.31% indicates weaker profitability. This means the company retains a smaller portion of each dollar in sales as profit compared to its competitors.
STE
11.26%
Health Care Equipment & Supplies Industry
- Max
- 23.34%
- Q3
- 13.06%
- Median
- 9.53%
- Q1
- 5.96%
- Min
- -3.87%
STE’s Net Profit Margin of 11.26% is aligned with the median group of its peers in the Health Care Equipment & Supplies industry. This indicates its ability to convert revenue into profit is typical for the sector.
Operating Profit Margin (TTM)
BRKR
4.93%
Life Sciences Tools & Services Industry
- Max
- 33.15%
- Q3
- 19.34%
- Median
- 13.02%
- Q1
- 8.05%
- Min
- -4.38%
BRKR’s Operating Profit Margin of 4.93% is in the lower quartile for the Life Sciences Tools & Services industry. This indicates weaker profitability from core operations, which may stem from inefficiencies or competitive pressures on pricing.
STE
16.01%
Health Care Equipment & Supplies Industry
- Max
- 29.44%
- Q3
- 17.80%
- Median
- 13.95%
- Q1
- 8.73%
- Min
- -3.56%
STE’s Operating Profit Margin of 16.01% is around the midpoint for the Health Care Equipment & Supplies industry, indicating that its efficiency in managing core business operations is typical for the sector.
Profitability at a Glance
| Symbol | BRKR | STE |
|---|---|---|
| Return on Equity (TTM) | 4.42% | 9.47% |
| Return on Assets (TTM) | 1.32% | 6.07% |
| Net Profit Margin (TTM) | 2.31% | 11.26% |
| Operating Profit Margin (TTM) | 4.93% | 16.01% |
| Gross Profit Margin (TTM) | 48.54% | 44.01% |
Financial Strength
Current Ratio (MRQ)
BRKR
1.61
Life Sciences Tools & Services Industry
- Max
- 4.76
- Q3
- 2.77
- Median
- 1.85
- Q1
- 1.40
- Min
- 0.43
BRKR’s Current Ratio of 1.61 aligns with the median group of the Life Sciences Tools & Services industry, indicating that its short-term liquidity is in line with its sector peers.
STE
1.96
Health Care Equipment & Supplies Industry
- Max
- 4.90
- Q3
- 3.05
- Median
- 2.14
- Q1
- 1.49
- Min
- 0.86
STE’s Current Ratio of 1.96 aligns with the median group of the Health Care Equipment & Supplies industry, indicating that its short-term liquidity is in line with its sector peers.
Debt-to-Equity Ratio (MRQ)
BRKR
1.35
Life Sciences Tools & Services Industry
- Max
- 1.75
- Q3
- 0.83
- Median
- 0.41
- Q1
- 0.18
- Min
- 0.00
BRKR’s leverage is in the upper quartile of the Life Sciences Tools & Services industry, with a Debt-to-Equity Ratio of 1.35. While this approach can boost equity growth, it also exposes the company to greater financial vulnerability.
STE
0.31
Health Care Equipment & Supplies Industry
- Max
- 1.49
- Q3
- 0.71
- Median
- 0.45
- Q1
- 0.14
- Min
- 0.00
STE’s Debt-to-Equity Ratio of 0.31 is typical for the Health Care Equipment & Supplies industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
Interest Coverage Ratio (TTM)
BRKR
14.89
Life Sciences Tools & Services Industry
- Max
- 29.61
- Q3
- 23.24
- Median
- 6.07
- Q1
- 2.18
- Min
- -14.08
BRKR’s Interest Coverage Ratio of 14.89 is positioned comfortably within the norm for the Life Sciences Tools & Services industry, indicating a standard and healthy capacity to cover its interest payments.
STE
11.23
Health Care Equipment & Supplies Industry
- Max
- 58.29
- Q3
- 25.56
- Median
- 9.06
- Q1
- 3.60
- Min
- -28.92
STE’s Interest Coverage Ratio of 11.23 is positioned comfortably within the norm for the Health Care Equipment & Supplies industry, indicating a standard and healthy capacity to cover its interest payments.
Financial Strength at a Glance
| Symbol | BRKR | STE |
|---|---|---|
| Current Ratio (MRQ) | 1.61 | 1.96 |
| Quick Ratio (MRQ) | 0.64 | 1.19 |
| Debt-to-Equity Ratio (MRQ) | 1.35 | 0.31 |
| Interest Coverage Ratio (TTM) | 14.89 | 11.23 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
BRKR
0.59%
Life Sciences Tools & Services Industry
- Max
- 1.80%
- Q3
- 0.78%
- Median
- 0.37%
- Q1
- 0.00%
- Min
- 0.00%
BRKR’s Dividend Yield of 0.59% is consistent with its peers in the Life Sciences Tools & Services industry, providing a dividend return that is standard for its sector.
STE
0.91%
Health Care Equipment & Supplies Industry
- Max
- 4.05%
- Q3
- 1.76%
- Median
- 0.71%
- Q1
- 0.00%
- Min
- 0.00%
STE’s Dividend Yield of 0.91% is consistent with its peers in the Health Care Equipment & Supplies industry, providing a dividend return that is standard for its sector.
Dividend Payout Ratio (TTM)
BRKR
38.32%
Life Sciences Tools & Services Industry
- Max
- 156.00%
- Q3
- 65.73%
- Median
- 23.81%
- Q1
- 0.00%
- Min
- 0.00%
BRKR’s Dividend Payout Ratio of 38.32% is within the typical range for the Life Sciences Tools & Services industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
STE
35.77%
Health Care Equipment & Supplies Industry
- Max
- 160.00%
- Q3
- 72.47%
- Median
- 27.49%
- Q1
- 0.00%
- Min
- 0.00%
STE’s Dividend Payout Ratio of 35.77% is within the typical range for the Health Care Equipment & Supplies industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
Dividend at a Glance
| Symbol | BRKR | STE |
|---|---|---|
| Dividend Yield (TTM) | 0.59% | 0.91% |
| Dividend Payout Ratio (TTM) | 38.32% | 35.77% |
Valuation
Price-to-Earnings Ratio (TTM)
BRKR
64.42
Life Sciences Tools & Services Industry
- Max
- 117.96
- Q3
- 65.59
- Median
- 37.26
- Q1
- 27.51
- Min
- 1.73
BRKR’s P/E Ratio of 64.42 is within the middle range for the Life Sciences Tools & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
STE
39.46
Health Care Equipment & Supplies Industry
- Max
- 73.48
- Q3
- 51.69
- Median
- 34.31
- Q1
- 25.74
- Min
- 11.47
STE’s P/E Ratio of 39.46 is within the middle range for the Health Care Equipment & Supplies industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
Price-to-Sales Ratio (TTM)
BRKR
1.49
Life Sciences Tools & Services Industry
- Max
- 12.46
- Q3
- 6.70
- Median
- 4.24
- Q1
- 2.68
- Min
- 0.73
In the lower quartile for the Life Sciences Tools & Services industry, BRKR’s P/S Ratio of 1.49 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.
STE
4.44
Health Care Equipment & Supplies Industry
- Max
- 9.53
- Q3
- 5.26
- Median
- 3.39
- Q1
- 2.13
- Min
- 0.00
STE’s P/S Ratio of 4.44 aligns with the market consensus for the Health Care Equipment & Supplies industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
Price-to-Book Ratio (MRQ)
BRKR
3.46
Life Sciences Tools & Services Industry
- Max
- 7.99
- Q3
- 4.69
- Median
- 3.30
- Q1
- 1.88
- Min
- 1.02
BRKR’s P/B Ratio of 3.46 is within the conventional range for the Life Sciences Tools & Services industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
STE
3.37
Health Care Equipment & Supplies Industry
- Max
- 10.85
- Q3
- 5.98
- Median
- 3.48
- Q1
- 2.43
- Min
- 0.69
STE’s P/B Ratio of 3.37 is within the conventional range for the Health Care Equipment & Supplies industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
Valuation at a Glance
| Symbol | BRKR | STE |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 64.42 | 39.46 |
| Price-to-Sales Ratio (TTM) | 1.49 | 4.44 |
| Price-to-Book Ratio (MRQ) | 3.46 | 3.37 |
| Price-to-Free Cash Flow Ratio (TTM) | 25.89 | 31.18 |